Nerve technology developer Orthocell (ASX:OCC) has received firm commitments from institutional investors to raise $13 million in a share placement. The company, which is commercialising its CelGro nerve regeneration product, received commitments for well in excess of the figure sought from existing and new investors. The company will also proceed with a share purchase plan…
Blood products and pharmaceutical group CSL (ASX: CSL) is continuing its focus on innovation, spending more that $1.21 billion (US$832 million) on research in 2019.
Cold Logic has entered into an agreement with Ernest West & Beynon to fulfil Australian Navy refrigeration needs.
Winners at the 57th Australian Export Awards were named at a ceremony at Parliament House, Canberra.
THC Global Group (ASX:THC) has completed the first farm-to-pharma processing of medicinal cannabis in Australia at its Southport manufacturing facility (pictured) in Queensland. The Southport Facility is the largest pharmaceutical bio-floral extraction facility in the Southern Hemisphere and is licenced and permitted to process medicinal cannabis. THC Global CEO Ken Charteris said: “Completing this Australian…
The Australian Space Agency signed a collaboration agreement with French communications and defence company Thales this week, one of numerous such agreements with nations, states and international and local space industry leaders signed by the young agency. Agency boss Dr Megan Clarke (pictured) has been acive signing alliances and said its new agreement with space…
